China Resources Double-Crane Pharmaceutical News and Activities

China Resources Double-Crane Pharmaceutical is one of the...

• CSI 500;
• TOB Iconic 10,000.

China Resources Double-Crane Pharmaceutical is a company listed under the stock ticker 600062 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at China Resources Double-Crane Pharmaceutical

• Wenchao Lu, Acting Chairman of the Board and President
• Shutian Yu, Director
• Xiaosong Bai, Director

Create your alert
to follow the executive moves at China Resources Double-Crane Pharmaceutical.

China Resources Double-Crane Pharmaceutical has 1,912 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by China Resources Double-Crane Pharmaceutical

Social media about China Resources Double-Crane Pharmaceutical

• China Resources Double-Crane Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• China Resources Double-Crane Pharmaceutical on LinkedIn, X (Twitter) & YouTube